olaparib,abiraterone
merck,astrazeneca,janssen
['olaparib', 'abiraterone', 'prostate', 'propel']
olaparib + abiraterone as 1st-line therapy in men with metastatic castration-resistant #prostatecancer: pharmacokinetics data from the #propel trial. presented by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology